Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular AMD

Authors not listed

Notal Vision Ltd. · 2011

Abstract

ForeseeHome, an FDA-approved home device, was specifically designed for unsupervised Preferential-Hyperacuity-Perimeter (PHP) testing of Age Related Macular Degeneration (AMD) patients at home by characterizing central and paracentral metamorphopsia . The purpose of the current study is to evaluate if, in post-treatment patients, PHP parameters as measured with the ForeseeHome are in agreement with clinical decisions and retinal characteristics as measured with optical coherence tomography (OCT).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Anonymous. (2011). Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular AMD. <em>Notal Vision Ltd.</em>. https://clinicaltrials.gov/study/NCT01334294
Vancouver
Anonymous. Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular AMD. Notal Vision Ltd.. 2011.
BibTeX
@misc{anon2011HomeVi, title = {Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular AMD}, author = {Anonymous}, journal = {Notal Vision Ltd.}, year = {2011}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings